| Target ID: | dt631 |
|---|---|
| CID: | 448281 |
| Compound Name: | Mln-4760 |
| Gene ID: | 183 |
| Gene Name: | AGT |
| Species: | Mus musculus (house mouse) |
| PubMed IDs: | 29969931 |
| Action: | 2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid inhibits the reaction [lipoxin A4 inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of AGT protein alternative form]] |
Knowledge Graph
| Target ID | CID | Compound Name | Gene ID | Gene Name | Species | Action | |
|---|---|---|---|---|---|---|---|
| dt630 | 448281 | Mln-4760 | 183 | AGT | Mus musculus (house mouse) | 2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid inhibits the reaction [angiotensin I (1-7) inhibits the reaction [AGT protein results in decreased abundance of angiotensin I (1-7)]]|2-(1-carboxy-2-(3-(3,5-dichlor | Details |
| dt632 | 448281 | Mln-4760 | 183 | AGT | Rattus norvegicus (Norway rat) | 2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid inhibits the reaction [ACE2 protein inhibits the reaction [lipopolysaccharides results in increased expression of AGT protein]]|2-(1-carboxy-2-(3-(3,5-dichlorobenzy | Details |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress | |
|---|---|---|---|---|---|---|---|
| Drug74 | ORE1001 | Chemical drug | -- | -- | -- | Under clinical trials | Details |
| Compound ID | Source ID | Source Type | Compound Name | Molecular Weight | Molecular Formula | Molecular Species | |
|---|---|---|---|---|---|---|---|
| No data available | |||||||
| Disease ID | Disease Name | Definition | Mechanism | |
|---|---|---|---|---|
| No data available | ||||
| Strategy ID | Therapy Strategy | Synonyms | Related Drugs | Mechanism | |
|---|---|---|---|---|---|
| No data available | |||||